Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes
about
TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN RoutesImpact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella species.Chlamydia pneumoniae CopD translocator protein plays a critical role in type III secretion (T3S) and infectionVaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.Chlamydia Outer Protein (Cop) B from Chlamydia pneumoniae possesses characteristic features of a type III secretion (T3S) translocator protein.Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA AdhesinInduction of mucosal immunity through systemic immunization: Phantom or reality?Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study.The genomic signatures of Shigella evolution, adaptation and geographical spread.Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants.Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4(+) T cells following parenteral immunization.Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection.A Novel Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental ChallengeThe Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLTCross-Protective Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain
P2860
Q27322386-528C3BFE-0A63-4664-AC1D-ACF654F5753EQ34889587-FB82FCDF-7DD7-4ED8-86DF-998E2A803AAAQ35193819-18D74BB5-C661-486F-8B41-B9C92081ED57Q35887055-94359E34-227C-4545-BD26-379C7A2D2291Q35946462-C2383011-A0B5-4A78-9976-F1EB0C0A1B0EQ35954456-21E68F46-4AFA-4B66-86F4-D68BB53E511FQ36473218-932D7422-9D54-43CF-BE59-651C4A0D2013Q37067286-23F3F434-B528-4677-A5B3-0C47A7A2B8A5Q37130744-C14B2CC0-1177-4F1E-94B4-D194CDF4489EQ37633069-5F5CC3FE-A5B5-450D-B91B-15B8733DD18BQ38753453-3A9C4F6E-5D1A-4BDB-941D-7A1AFC3780E3Q38776163-B7C49C5B-7F1F-47E9-AF46-85C4E14FD2FDQ38818721-D88C99D9-F431-4A46-9458-E7FB38B5B5FDQ40100679-ABF7C0F0-6234-47AB-A293-1B16FDD11775Q47120596-08BBAC77-08CD-4469-BE80-DC9BB1DBADE9Q57929967-F9062908-EAB4-46C2-B498-CFC23A2B2954Q57945015-2F68FA67-2591-451F-B132-BB1804BF235FQ59138059-B901E54C-E704-4F0B-A1C1-987EA760B997
P2860
Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intradermal delivery of Shigel ...... nd protection across serotypes
@en
Intradermal delivery of Shigel ...... d protection across serotypes.
@nl
type
label
Intradermal delivery of Shigel ...... nd protection across serotypes
@en
Intradermal delivery of Shigel ...... d protection across serotypes.
@nl
prefLabel
Intradermal delivery of Shigel ...... nd protection across serotypes
@en
Intradermal delivery of Shigel ...... d protection across serotypes.
@nl
P2093
P2860
P356
P1476
Intradermal delivery of Shigel ...... nd protection across serotypes
@en
P2093
Cinthia B Drachenberg
Jovita Diaz-McNair
Lillian van de Verg
Marcela F Pasetti
Richard Walker
Shannon J Heine
Wendy L Picking
P2860
P304
P356
10.4049/JIMMUNOL.1302743
P407
P50
P577
2014-01-22T00:00:00Z